Literature DB >> 7718967

The first case of polymyositis associated with interferon therapy.

M Matsuya1, T Abe, M Tosaka, K Yonezawa, A Ono, N Ikeda, Y Yoshida, Y Akahonai, S Kurokawa, T Hayashi.   

Abstract

A 54-year-old man with renal cell carcinoma was treated with interferon (IFN)-gamma for 3 weeks soon after nephrectomy. Three months later he received IFN-alpha therapy for 8 weeks due to chronic active hepatitis C. He subsequently contracted polymyositis (PM): proximal muscle weakness, an elevation of muscle enzymes, myogenic patterns on the electromyograph and histologically specific findings in biopsied muscle specimens. After discontinuation of IFN his muscular weakness gradually recovered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7718967     DOI: 10.2169/internalmedicine.33.806

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

Review 1.  Cytokine-induced autoimmune disorders.

Authors:  P Miossec
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

2.  A case of polymyositis in a chronic hepatitis C patient treated with peg-interferon-alpha 2b and ribavirin therapy.

Authors:  Yusuke Okuma; Kiminori Kimura; Shunichi Saeki; Tsunekazu Hishima; Seishu Hayashi
Journal:  Clin J Gastroenterol       Date:  2009-08-06

Review 3.  Syphilitic myositis: a case-based review.

Authors:  Elaine Yacyshyn; Praveena Chiowchanwisawakit; Derek J Emery; Jack Jhamandas; Lothar Resch; Geoffrey Taylor
Journal:  Clin Rheumatol       Date:  2011-01-07       Impact factor: 3.650

Review 4.  Dermatomyositis as a complication of interferon-α therapy: a case report and review of the literature.

Authors:  Hideyuki Shiba; Tohru Takeuchi; Kentaro Isoda; Yasuhito Kokunai; Yumiko Wada; Shigeki Makino; Toshiaki Hanafusa
Journal:  Rheumatol Int       Date:  2014-03-18       Impact factor: 2.631

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.